Artiva Biotherapeutics, Inc. (ARTV) AI Dilution Summary

Estimated cash was $322,867,000 as of 2026-10-27, rolled forward from $349,394,000 at the 2026-06-30 balance-sheet date against estimated monthly burn of $6,785,000. The most recent capital raised was a public offering closed 2026-05-11 for $299,999,752.27 gross, issuing 23,871,526 shares at $11.52; those proceeds are already inside the 2026-06-30 cash figure. Dilution is driven primarily by the active ATM program with Leerink Partners LLC, authorised to $100,000,000.